![Mark Brewer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mark Brewer worked as the Director of Life Sciences at Eden Financial Ltd. from 2011 to 2012.
He then served as an Analyst at Dresdner Kleinwort Securities Ltd. in 2005.
Dr. Brewer later worked as an Analyst at WHI Stockbrokers Ltd. from 2012 to 2013, and at Hardman Research Ltd. from 2013 to 2016.
He concluded his career as the Director of Research at Cavendish Capital Markets Ltd. from 2019 to 2023.
Eerdere bekende functies van Mark Brewer
| Bedrijven | Functie | Einde |
|---|---|---|
Cavendish Capital Markets Ltd.
 Cavendish Capital Markets Ltd. Investment Banks/BrokersFinance Provides brokerage services | Directeur van Onderzoek - Eigen Vermogen | 31-12-2023 |
Hardman Research Ltd.
 Hardman Research Ltd. Investment ManagersFinance Provides investment research | Analyst-Equity | 01-01-2016 |
WHI Stockbrokers Ltd.
 WHI Stockbrokers Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-05-2013 |
Eden Financial Ltd.
 Eden Financial Ltd. Investment ManagersFinance EF is an active investment manager following a flexible, multi-strategy investment approach tailored to their clients' profile. They favor asset diversification and balanced portfolios. Investment decisions are based on in-depth proprietary research which pays particular attention to market trends. EF invests globally in equity, gilts and bonds, focusing on the UK. They also invest in other asset classes including emerging market securities and private or public company growth capital. In particular, they invest in private equity, pre-IPO funding, IPO operations and secondaries. EF has specialist expertise in the pharmaceutical and healthcare sectors, biotechnology and medical devices. They acquire significant stakes in innovative companies, and promote their growth. They favor companies with strong IP protection. | Director of Investments | 02-03-2010 |
Dresdner Kleinwort Securities Ltd.
 Dresdner Kleinwort Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 21-02-2005 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
64
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Dresdner Kleinwort Securities Ltd.
Dresdner Kleinwort Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
WHI Stockbrokers Ltd.
WHI Stockbrokers Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Hardman Research Ltd.
Hardman Research Ltd. Investment ManagersFinance Provides investment research | Finance |
Eden Financial Ltd.
Eden Financial Ltd. Investment ManagersFinance EF is an active investment manager following a flexible, multi-strategy investment approach tailored to their clients' profile. They favor asset diversification and balanced portfolios. Investment decisions are based on in-depth proprietary research which pays particular attention to market trends. EF invests globally in equity, gilts and bonds, focusing on the UK. They also invest in other asset classes including emerging market securities and private or public company growth capital. In particular, they invest in private equity, pre-IPO funding, IPO operations and secondaries. EF has specialist expertise in the pharmaceutical and healthcare sectors, biotechnology and medical devices. They acquire significant stakes in innovative companies, and promote their growth. They favor companies with strong IP protection. | Finance |
Cavendish Capital Markets Ltd.
Cavendish Capital Markets Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
